Latest On-Demand Webinars & Online Events

In this webinar series, experts from Thermo Fisher Scientific will explore a range of benefits that a chromatography data system can provide to IT system administrators and lab managers, from backup and disaster recovery to a solution for remote working.

As organizations look to build and execute digital transformation strategies, a major focus is how to improve the scientific experience. To maximize the output of the lab, scientists need to be able to rely on technological advancements, innovative software and improved processes.

Even with robust quality systems governing your analytical laboratory and a strong data integrity (DI) program in place, you may still be nervous about preparing for a regulatory inspection. What will the inspectors want to know? What will they ask? Is your team prepared?

Accessed via mobile, tablet or PC, this inaugural free-to-attend event will provide those working within academia and pharmaceutical development the opportunity to hear from experts within the field. Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology.

Organizations, across all scientific industries, are assessing their digital transformation journey to try and map out the key strategies to achieving a fully digitally enabled laboratory. The key to creating and implementing a digital strategy is determining where efficiencies can be made and where technologies can provide a competitive edge.

In this webinar, data integrity expert Bob McDowall explains how to ensure the integrity and compliance of reported data, from sampling to reporting.

Watch this webinar to learn how to enable and manage 21 CFR Part 11 in the lab whilst adopting simplified workflows to ensure compliance from each analyst.

Watch this webinar to learn how to streamline your sample submission and analysis request process. You will also learn to review data using dashboard features and reporting tools.

Surveillance analysis of potentially pathogenic microbes found in shared public resources is an important component of research aimed at understanding, preparing for, and protecting communities from potential widespread infection and transmission of infectious diseases.

Vanderbilt University Medical Center researchers Robert Carnahan and Pavlo Gilchuk are attempting to compress the timeline for therapeutic antibody development, by integrating a series of advances in single-cell messenger RNA sequence analysis, bioinformatics, synthetic biology and high-throughput functional analysis.